Exenatide Improves Glucose Homeostasis and Prolongs Survival in a Mouse Model of Heart Failure
Author Information
Author(s): Vyas Arpita Kalla, Yang Kai-Chien, Woo Dennis, Tzekov Anatoly, Kovacs Attila, Jay Patrick Y., Hruz Paul W.
Primary Institution: Washington University School of Medicine
Hypothesis
Can pharmacologic enhancement of insulin sensitivity and myocardial glucose uptake preserve cardiac function and survival in heart failure?
Conclusion
Exenatide treatment improves glucose tolerance, cardiac function, and survival in mice with dilated cardiomyopathy.
Supporting Evidence
- Exenatide improved glucose tolerance in TG9 mice.
- Cardiac function was significantly better in exenatide-treated mice.
- Survival was prolonged in exenatide-treated mice compared to controls.
Takeaway
This study shows that a diabetes drug called exenatide helps mice with heart problems by making their bodies better at using sugar and helps them live longer.
Methodology
Exenatide was administered to TG9 mice starting at 56 days of age, and glucose tolerance, cardiac function, and survival were assessed.
Limitations
The study is limited to a mouse model, and results may not directly translate to humans.
Participant Demographics
TG9 mice, a transgenic model of dilated cardiomyopathy.
Statistical Information
P-Value
p<0.01
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website